The B-cell receptor (BCR) transmits a tonic survival signal in the absence of antigen stimulation and an antigen-triggered survival signal. Mature B cells express two types of BCR, IgM and IgD, but it remains unclear how B-cell survival is differentially regulated by these two receptors. We found that, whereas cross-linking IgM on 
| INTRODUCTION
Immature B cells in the bone marrow (BM) express IgM BCR and are susceptible to apoptosis upon self-antigen (Ag) stimulation (Melchers, 2015; Pelanda & Torres, 2012; Tsubata, 2017 (Geisberger, Lamers, & Achatz, 2006; Kim & Reth, 1995) .
In mature B cells, Ag binding to the BCR initiates a cascade of signaling events that eventually lead to enhanced B-cell survival and activation (Kurosaki, 2011) . In addition, even in the absence of Ag binding, BCR constitutively transmits a tonic survival signal, as showed by the finding that in vivo ablation of BCR expression in mice caused rapid death of B cells (Kraus, Alimzhanov, Rajewsky, & Rajewsky, 2004; Lam, Kühn, & Rajewsky, 1997; Srinivasan et al., 2009 ).
The importance of IgM BCR in B-cell survival and activation is well documented. Stimulation of spleen B cells with F(ab') 2 α-IgM antibodies (Abs) induces enhanced B-cell survival and activation (Ouchida et al., 2012 (Ouchida et al., , 2015 . In contrast, the function of IgD BCR in tonic and Ag-triggered B-cell survival remains less clear. It was shown that cross-linking IgM, but not IgD, in B-cell transfectants induced apoptosis (Alés-Martínez, Warner, & Scott, 1988; Tisch, Roifman, & Hozumi, 1988) . Consistent with these observations, ectopic expression of IgD in immature B cells interfered with their apoptosis induced by cross-linking IgM (Carsetti, Köhler, & Lamers, 1993) . Kim and Reth (1995) found that crosslinking IgM or IgD can both activate tyrosine kinases and induce Ca 2+ influx but the kinetics and intensity of the tyrosine phosphorylation were different. In addition, injection of α-IgD Abs resulted in significant decreases of the IgM low B cells in mice, suggesting that IgD may mediate a negative signal in B cells (Finkelman, Holmes, Dukhanina, & Morris, 1995) . Furthermore, cross-linking IgD with low doses of α-IgD Abs induced more apoptosis than cross-linking IgM (Kozono, Kotzin, & Holers, 1996; Peckham, AndersenNissen, Finkelman, Stunz, & Ashman, 2001 ). More recently, it was found that Ag with low valence only activated IgM receptors but polyvalent Ag activated both IgM and IgD receptors (Übelhart et al., 2015) . These results collectively suggest that IgM and IgD have distinct response to Ag stimulation. In contrast to the findings that IgM and IgD signal differently, it was recently reported that IgM and IgD induced a similar Ca 2+ response when stimulated with a monomeric Ag (Sabouri et al., 2016) . In addition, transgenic mice with B cells expressing IgM or IgD alone had relatively normal Bcell activation and tolerance (Brink et al., 1992) . Consistently, mice lacking IgD (Nitschke, Kosco, Köhler, & Lamers, 1993; Roes & Rajewsky, 1993) or IgM (Lutz et al., 1998) showed normal B-cell development and maturation and relatively normal humoral immune responses. 
| RESULTS

| B-cell viability correlates with Igκ levels
To clarify the relationship between the total BCR (Igκ) levels and B-cell survival, we analyzed the changes of Igκ levels and B-cell viability during in vitro culture in the absence of extrinsic stimuli. As shown in Figure 1a , Igκ levels gradually decreased during culture, with a kinetics similar to the decrease in IgM levels observed in our recent study (Yasuda, Zhou, Wang, Yamamura, & Wang, 2017) , implicating that IgM and IgD decreased similarly. B-cell viability concomitantly decreased during the culture (Figure 1b) , with B cells expressing high levels of Igκ (Igκ high ), had significantly increased viability than Igκ low cells (Figure 1c) . Conversely, the mean fluorescence intensity (MFI) of Igκ in live cells was approximately two times higher than that in dead cells (Figure 1d ). Thus, B-cell viability correlated with Igκ levels.
| Cross-linking IgD does not enhance but inhibits the survival of spleen B cells
It is well known that F(ab') 2 α-IgM Abs can induce the survival and activation of mature B cells. As shown in Figure 2 , F(ab') 2 α-IgM Abs significantly enhanced B-cell survival at either 10 or 30 μg/ml doses (open columns). It is less clear, however, whether cross-linking IgD in mature B cells can enhance B-cell survival. To address this point, we stimulated spleen B cells with an α-IgD monoclonal Ab (mAb, AMS-9.1), which has previously been shown to induce Bcell activation as evidenced by capping of surface IgD and increased 3 H-thymidine uptake (Goroff, Stall, Mond, & Finkelman, 1986) . Consistent with these earlier findings, AMS-9.1, but not an isotype-matched control IgG, increased the forward scatter (FSC), which represents cell sizes (Supporting information Figure S1 ), suggesting that crosslinking IgD did trigger signal transduction. Surprisingly, B-cell viability was not enhanced, but decreased dose-dependently in the presence of α-IgD (Figure 2 , gray columns). The control IgG had little effect on B-cell viability at either 30 or 90 μg/ml dose ( Figure 2 , solid columns). These observations indicate that, although cross-linking IgD on mature B cells could transmit a signal that led to increased cell sizes (Supporting information Figure S1 ), capping of IgD and increased 3 H-thymidine uptake (Goroff et al., 1986) , and increased Ca 2+ influx and tyrosine phosphorylation (Übelhart et al., 2015) , such a signal appears insufficient to eventually enhance B-cell survival. On the contrary, cross-linking IgD with high doses of α-IgD Ab inhibited B-cell survival (gray columns). A similar result was obtained with α-IgD serum (Supporting information Figure S2 ). To validate the inhibitory effect of cross-linking IgD on B-cell survival, we then stimulated both IgM and IgD with F(ab') 2 α-Igκ Abs as the majority of the mouse B cells use Igκ light chains. As expected, F(ab') 2 α-Igκ Abs only moderately increased B-cell viability at a high dose (100 μg/ml) ( Figure 2 , hatched columns). These results suggest that cross-linking IgD attenuates IgM-induced B-cell survival. Genes to Cells YASUDA et Al. ml) did not enhance, but rather decreased, B-cell viability, as compared with nonstimulated cells. To investigate whether cross-linking Igκ gave similar results, we stimulated spleen B cells with a wide range of F(ab′) 2 α-Igκ Abs for 18, 48, and 72 hr. Similar to F(ab′) 2 α-IgM Abs, low doses of F(ab′) 2 α-Igκ Abs also resulted in decreased viability as compared with nonstimulated cells (Figure 3a ). However, there was a clear difference in the Ab doses required to enhance B-cell survival between F(ab′) 2 α-IgM and F(ab′) 2 α-Igκ Abs. In the case of F(ab′) 2 α-IgM Abs, 10 μg/ml dose readily gave a higher viability than nonstimulated cells at both 48 and 72 hr after culture (Yasuda et al., 2017) . In contrast, 90 μg/ ml of F(ab′) 2 α-Igκ Abs was required to give a moderately higher viability than nonstimulated cells only at 72 hr after culture ( Figure 3a ). These observations indicate that, when cross-linking both IgM and IgD with F(ab′) 2 α-Igκ Abs, a much higher dose is needed to induce B-cell survival, consistent with an inhibitory role for IgD on IgM-induced B-cell survival.
| B-cell survival is moderately enhanced when most of the IgM and IgD are bound by the F(ab′)2 α-Igκ Abs
We have recently found that B cells stimulated with F(ab′) 2 α-IgM Abs show enhanced survival compared with nonstimulated cells when more than 72% of their cell surface IgM BCR are cross-linked. We next sought to determine the proportion of cross-linked IgM and IgD required for enhanced B-cell survival. For this purpose, we first stained B cells with different concentrations of PE-conjugated α-mouse Igκ Ab and analyzed the proportion of the surface Igκ that was bound by the Ab. We stained B cells with 0.1, 0.2, 0.4 0.6, 1.8, 6, 18, 60, and 180 μg/ml of PE-conjugated α-Igκ Ab, which had roughly the same molar concentration as 0.05, 0.1, 0.2, 0.3, 0.9, 3, 9, 30, and 90 μg/ ml of the F(ab′) 2 α-Igκ Abs, respectively. As shown in Figure 3b , the MFI reached a plateau at 180 μg/ml of the PE-labeled α-Igκ Ab (solid circles), which corresponded to 90 μg/ml of the F(ab′) 2 anti-Igκ Abs taking into consideration that PE-labeled α-Igκ Ab had roughly twice the molecular weight of the F(ab′) 2 anti-Igκ Abs. As B-cell survival was enhanced only at 90 μg/ml of F(ab′) 2 anti-Igκ Abs (Figure 3a ), we conclude that only when most of the surface Igκ are cross-linked by the F(ab′) 2 α-Igκ Abs can B-cell survival be enhanced. Figure 4b ), suggesting that the IgD level was roughly five times higher than the IgM level. To verify this result, we further carried out immunoblot analysis using Abs that recognize the μ or δ chain ( Figure 4c) . The results showed that the band intensity of δ chain (26,846) was roughly five times higher than that of μ chain (5,555), consistent with the data obtained with FACS ( Figure 4b 
| The average levels of IgD are five times higher than that of IgM in spleen B cells
| Mathematical modeling of IgM-and
IgD-mediated tonic and Ag-triggered survival signals in mature B cells
A scheme for IgM-and IgD-mediated signals in each B cell is illustrated in Figure 5 . We first determined the saturation condition for α-Igκ Ab binding. Based on the experimental data shown in Figure 3b (solid circles), k 2 /k 1 was determined to be 1.034 [μg/ml], using the weighted least squares method (detailed method is described in Experimental Procedures). To further determine the values of k 1 and k 2 , we analyzed the binding kinetics of PElabeled α-Igκ Ab at 2 μg/ml dose (equivalent to 1 μg/ml of F(ab') 2 α-Igκ Abs) (Figure 6a ). Based on this result, k 1 and k 2 were determined to be 3.599 [ml/μg/hr] and 3.722 [/hr], respectively. The values of k 1 and k 2 indicated that cross-linking reached 97% saturation in 30 min in the presence of 1 μg/ml of the F(ab′) 2 α-Igκ Abs. Theoretically, 87% saturation is achieved in 30 min in the presence of 0.1 μg/ml of the F(ab′) 2 α-Igκ Abs, whereas 99% saturation is achieved in just 7 min in the presence of 10 μg/ml of the F(ab′) 2 α-Igκ Abs. We next determined the rate of Igκ degradation. Based on the changes in Igκ levels during culture (Figure 1a) , d 1 was determined to be 0.01163 [/hr] using the weighted least squares method. The simulation of Genes to Cells
the decrease in Igκ levels is shown in Figure 6b (red line), which indicated that Igκ BCR levels decreased by 57% in 72 hr, which was quite similar to the decrease in IgM levels (Yasuda et al., 2017) . We used genetic algorithm (GA) to calculate the values of the parameters k 3 , k 4 , k 5 , d 2 , and deadline to allow the model to best fit with the actual survival data shown in , and 0.02888, respectively. As described in section 4.13, the initial average values of Signal(on) were set to 0.1 and a cell would die when the value of Signal(on) dropped below 0.02888, which we call deadline. The survival curves depicted from these parameters are shown in Figure 7a (red lines), which well matched the trend of the actual data (solid circles). Our model also predicts a survival curve shown in Figure 7b (red line) when only IgD is cross-linked, which also matched very well the actual data (solid circles, adopted from Figure 2 ). 
| DISCUSSION
It was shown more than 30 years ago that cross-linking IgD with an α-IgD Ab (AMS-9.1) induced capping of IgD and increased 3 H-thymidine uptake (Goroff et al., 1986) , suggesting that IgD is able to transmit an activation signal. Cross-linking IgD was also shown to induce Ca 2+ influx and tyrosine phosphorylation of signaling molecules (Kim & Reth, 1995; Übelhart et al., 2015) . These observations implicate that IgD can initiate signal transduction upon Ag binding. However, it remains unknown whether IgD-induced signal can really lead to increased survival in primary B cells. We found that cross-linking IgD with AMS-9.1 increased cell sizes but did not enhance B-cell survival. On the contrary, AMS-9.1 inhibited B-cell survival in a dose-dependent manner. Analysis of IgD-deficient mice showed that IgD promoted the accumulation of mature B cells in vivo (Nitschke et al., 1993; Roes & Rajewsky, 1993) . These observations collectively suggest that IgD can transmit a tonic survival signal and that crosslinking IgD not only fails to generate a survival signal but also disrupts its tonic signal, resulting in decreased viability. This conclusion is further supported by the finding that F(ab') 2 α-Igκ Abs, which stimulate both IgM and IgD, only moderately enhance B-cell survival, likely due to IgD-mediated inhibition of IgM-induced survival signal. Notably, mice lacking IgM were shown to have relatively normal B-cell development and maturation (Lutz et al., 1998) , which led to the conclusion that IgD can largely substitute for loss of IgM function. However, IgM-deficient mice had reduced IgD + CD5
+ B-1a population in the peritoneal cavity (Lutz et al., 1998) , which is typically observed in mice with reduced BCR signaling, indicating that IgD alone cannot generate a signal that is as strong as that in WT B cells. Consistently, IgM-deficient mice showed reduced or delayed Ab production against a T-D Ag and in response to virus infection (Guo, Zhang, Zheng, & Han, 2008; Han et al., 2004; Lutz et al., 1998) . More importantly, the finding that IgD is able to function when IgM is absent does not necessarily mean that IgD has the same function when IgM is present. It is conceivable that, in the absence of IgM, IgD can now use signaling molecules that are normally associated with IgM, allowing it to function instead of IgM. We think that, when both IgM and IgD are present, cross-linking IgD can only trigger Ca 2+ influx, tyrosine phosphorylation, and increased cell sizes, but is unable to enhance B-cell survival. Our model is consistent with the observation in IgD-deficient mice where IgM levels increased by twofold (Nitschke et al., 1993) presumably to compensate for the lack of IgDmediated tonic signal. In addition, in the IgD heterozygotes B cells expressing the IgD − allele had reduced representation in the spleen compared with those expressing WT allele (Nitschke et al., 1993) , consistent with a role for IgD in generating a tonic survival signal. IgD-deficient mice also showed moderately increased IgM production against a Tindependent type II Ag (Roes & Rajewsky, 1993 ) and a T-D 
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Ag (Nitschke et al., 1993) , in agreement with our conclusion that IgD inhibits Ag-triggered, IgM-induced B-cell survival. We have recently modeled IgM-mediated tonic and Agtriggered survival signals. We found that cross-linking more than 72% of the surface IgM was required to enhance B-cell survival. In the current study, we included both IgM and IgD in our model and found that almost all the BCR (IgM and IgD) needed to be cross-linked in order to induce the survival of mature B cells. Thus, in the presence of both IgM and IgD, a much stronger Ag stimulation is required to induce B-cell survival and subsequent proliferation. Our model also shows that the total amount of IgD-mediated tonic signal is 66% of that generated from IgM BCR ( (Hardy, 2006; Rothstein, Herzenberg, Holodick, & Ghosn, 2015) . Interestingly, B-1 cells only express IgM, which we think allows them to survive and proliferate in response to self-Ag stimulation. In addition, marginal zone B cells express higher levels of IgM and lower levels of IgD compared with follicular B cells, and indeed, it has been shown that marginal zone B cells, but not follicular B cells, can be activated by self-Ag and differentiate into plasma cells that secrete autoantibodies (Mandik-Nayak, Racz, Sleckman, & Allen, 2006) .
We have modeled IgM-and IgD-mediated tonic and Aginduced survival signals based on the experimental results and the finding that IgD levels are five times higher than IgM levels in mature B cells. However, careful calibration using additional reagents is needed to accurately measure the relative expression of IgM and IgD. In addition, the actual ratio of IgD to IgM is different from one cell to another, with some cells expressing more IgD relative to IgM and others more IgM relative to IgD. To more precisely model IgM-and IgD-mediated signals, it would be necessary to measure the amount of IgM and IgD in individual B cell. This is quite difficult as different fluorescence-labeled Ab can simultaneously detect IgM and IgD on each B cell but cannot correctly estimate their relative amount due to the differences in the intensity of different fluorescent dyes. More advanced technologies are required to determine the relative IgM and IgD levels on each B cell. Another limitation of our study is that we used Abs, not Ag, to stimulate IgM and/or IgD. It is possible that differences in the affinity of these Abs as well as the epitopes they recognize may affect B-cell survival responses. B cells from Ag-specific BCR-transgenic mice express IgM and IgD with the same specificity and can be stimulated by the same Ag, but it would be difficult to stimulate IgM and IgD separately. Despite the limitations of our study, our model correctly predicts the survival probability of BCR-stimulated mature B cells and is also consistent with the differential response of various B-cell subsets that express different levels of IgM and IgD. Our model thus provides new insights into the regulatory mechanisms for B-cell activation and tolerance.
| EXPERIMENTAL PROCEDURES
| Mice
C57BL/6 mice were purchased from Shanghai SLAC Laboratory Animal Corporation and maintained in specific pathogen-free conditions. All animal experiments were approved by the Ethical Committee and the animal facility of Fudan University. In addition, all experiments were carried out in accordance with the guidelines and regulations of Fudan University.
| B-cell culture and survival assay
Primary B cells were purified from the spleen of C57BL/6 mice using a mouse B lymphocyte enrichment set (Cat# 557792, BD Biosciences) as described previously (Ouchida et al., 2012 (Ouchida et al., , 2015 Yasuda et al., 2017) were stained with 7-amino-actinomycin D (7-AAD), and the percentages of viable (7-AAD low FSC high ) and dead (7-AAD high FSC low ) cells were analyzed by a FACSVerse flow cytometer (BD Biosciences). 
| Analysis of total BCR (Igκ) levels
| Comparison of IgM and IgD levels
To compare the expression levels of IgM and IgD, we took two different approaches. First, we stained spleen B cells with FITClabeled α-mouse IgM (Cat no. 553408, BD Biosciences) or FITC-conjugated anti-mouse IgD (Cat no. 405703, BioLegend) separately and compared their MFI. The F/P ratio is 4.1 for both Abs indicating that the relative level of FITC per molecule is similar between these two FITC-labeled Abs. In addition, we analyzed protein levels of μ and δ heavy chains by immunoblot with α-mouse IgM (Cat no. 553408, BD Biosciences) or α-mouse IgD (Cat no. 405703, BioLegend), followed by HRPconjugated α-rat IgG (Cat no. 81-9520, ZYMED). The band intensity was determined by a Molecular Imager (Fujifilm).
| Mathematical modeling of Igκ degradation in B cells
A scheme for IgM-and IgD-mediated signals in each cell is illustrated in Figure 5 . MFI of IgM and IgD decreased during culture due to a decrease in their expression level in each B cell. The IgM and IgD level in each B cell is different and could be converted to a value between 0 and 1, with the average level being 0.1. As we found that IgM and IgD levels decreased similarly, the changes in IgM and IgD levels in individual B cell are shown by the following equations:
where d 1 is the rate of Igκ degradation.
| Modeling of α-Igκ Abs binding to
IgM and IgD
A scheme for F(ab′) 2 α-Igκ Abs binding to and release from the surface IgM/D is illustrated in Figure 5 and can be expressed as the following equilibrium:
IgD -Ig 
IgM survival signal
Our recent study (Yasuda et al., 2017) showed that the strength of tonic IgM survival signal correlated with IgM
Genes to Cells YASUDA et Al. levels (MFI), and the tonic IgM signal can be expressed by the following reaction:
where k 3 is the rate constant of the survival signal generation dependent on IgM Free . d 2 is the rate constant of the signal consumption to maintain B-cell viability. Thus, the tonic signal generated from IgM can be expressed as the following equations:
4.8 | Modeling of Ag-triggered IgM survival signal
As described recently (Yasuda et al., 2017) , Ag-triggered, IgM-mediated survival signal is expressed by the following reaction and differential equation:
where k 4 is the rate constant of the survival signal generation dependent on IgM α-Igκ . There is a threshold (or offset) for B-cell response, and we have recently found that the offset is equivalent to the signal generated by cross-linking 61% of the surface IgM BCR (Yasuda et al., 2017) . Thus, the net amount of the survival signal (tonic + [offset Ag-triggered] -signal consumption) can be expressed by the following revised equation:
where (IgM α-Igκ -IgM · Offset) should be set to 0 if IgM α-Igκ is smaller than (IgM · Offset).
| Modeling of Ag-triggered IgD survival signal
Similar to IgM BCR, the tonic signal generated from IgD can be expressed by the following reaction and the differential equation.
where k 5 is the rate constant of the survival signal generation dependent on IgD Free . Our experimental results indicate that survival signal is not generated from cross-linked IgD.
| Integrating tonic IgM, Ag-triggered
IgM, and tonic IgD survival signals
Survival signal of a B cell can be expressed by the following differential equation:
If dSignal on /dt is smaller than 0, then the amount of tonic signal will keep decreasing. We think that, when the amount of tonic signal decreased to a certain level (which we call Deadline), a B cell will die. The final scheme showing both the tonic and Ag-triggered signals is illustrated in Figure 5 .
| Parameter optimization using weighted least squares method
The d 1 , k 1 , and k 2 variables were determined with the weighted least squares method to allow the model to best fit with the experimental results. We defined the error value based on the following equation to reduce the influence of the data with large SD and to increase the influence of the data with small SD.
In the above equation, J is the error value (sum of the weighted squared difference), n is the number of experiments, y is the experimental data, and σ is the SD of the data. The variables of the model (f) were determined to obtain the smallest value of J. 4.12 | Parameter optimization using genetic algorithm (GA)
As described previously, we used REX (real-coded ensemble crossover) and JGG (just generation gap) methods (Akimoto, Hasada, Sakuma, Ono, & Kobayashi, 2007; Kita & Yamamura, 1999; Kobayashi, 2009) of parameters k 3 , k 4 , k 5 , d 2 , and Deadline, which cannot be directly determined from the experimental data. GA was carried out to allow the model to best fit with the actual survival data of 0, 0.3, 0.9, 3, 9, 30, and 90 μg/ml of F(ab′) 2 α-Igκ Abs at 0, 18, 48, and 72 hr (a total of 28 data points). First, 180 individuals with different set of parameters were created as the population of the first generation. Each individual has d 1 , k 1 , and k 2 , which were determined from experimental data and randomly created values within 0~0.2 for k 3 , k 4 , k 5 , d 2 , and Deadline. The n + 1 generation was created from n generation as outlined in Supporting information Figure S3 . GA was terminated when the mean value of the sum squared difference among the population was almost the same as that of the smallest value, which means that the obtained parameter is the best fit. We generated random numbers using Mersenne Twister method (Matsumoto & Nishimura, 1998) . We also carried out GA side by side using 20 different random number seeds and obtained similar parameters. The calculated parameters are listed in Table 1 .
| Computer simulation of Bcell viability
Based on the differential equations obtained for the tonic IgM, Ag-triggered IgM, and tonic IgD survival signals, we calculated the changes of the following five variables in each cell: IgM, IgD, IgM α-Igκ , IgD α-Igκ , and Signal on using the highly accurate fourth-order Runge-Kutta method. The initial value of each variable was defined as in the following: Initial IgM (MFI) or IgD (MFI) was converted to a value between 0 and 1 with the average being set as 0.1. IgM α-Igκ and IgD α-Igκ were set to 0. As the strength of the survival signal before culture correlated with the initial expression levels of IgM and IgD and considering the influence of IgM (k 3 ) and IgD (k 5 ), the value of (k 3 ·IgM + k 5 ·IgD) was equivalent to Signal On , the average of which was converted to 0.1. Each of the five variables was calculated for every 0.01 hr interval between time 0 and 72 hr, and a cell was predicted to die when the value of Signal On dropped below the Deadline. Simulation was carried out for 200 representative cells at each dose of the F(ab′) 2 -α-Igκ Ab, and the viability was determined based on the predicted fate of these 200 cells. Parameters without initial value range were calculated based on experimental data, and those with initial value range were optimized using GA. The variations in the optimal value in the 20 seeds of random numbers are shown.
T A B L E 1 Optimized parameters used in the model
Parameter
